MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status
Kim, H, 정진행, Yang, JM, Jin, Y, 전상훈, 김관민, 이춘택, Paik, JH
ONCOTARGET, 2017
72
PD-L1 immunohistochemical assays for assessment of therapeutic strategies involving immune checkpoint inhibitors in non-small cell lung cancer: a comparative study
ONCOTARGET, 2017
73
Proposal of a Provisional Classification of Sebaceous Carcinoma Based on Hormone Receptor Expression and HER2 Status
정진행, Na, HY, Choe, JY, Shin, SA, 정호경, Oh, S, Park, M, 김지은
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016
74
Radiogenomic correlation in lung adenocarcinoma with epidermal growth factor receptor mutations: Imaging features and histological subtypes
Hong, SJ, Kim, TJ, 정진행, Choi, YW, Park, JS, 이경원
EUROPEAN RADIOLOGY, 2016
75
Prognostic value of wingless-type proteins in non-small cell lung cancer patients: A meta-analysis
Ping Zhan, Jiajia Jin, 정진행, Hong Qian, Xiaoxia Wang, Masaru Katoh, Kevin Phan, Tangfeng Lv, Yong Song
TRANSLATIONAL LUNG CANCER RESEARCH, 2016
76
Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma
이춘택, 전상훈, 김관민, 정진행, 김지은, Park E, Sun PL, Park SY, Jin Y, Kim H
ONCOTARGET, 2016
77
Expression of Na+-K+-2Cl(-) cotransporter isoform 1 (NKCC1) predicts poor prognosis in lung adenocarcinoma and EGFR-mutated adenocarcinoma patients
정진행, Yan Jin, Soo Young Park, Hyojin Kim, Eunhyang Park, 전상훈, 김관민, 이춘택, Ping-Li SUN
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016
78
Radiologic Characteristics of Surgically Resected Non-Small Cell Lung Cancer With ALK Rearrangement or EGFR Mutations
Kim, TJ (Kim, T, 정진행, 이춘택, 전상훈, Park, JS (Park
ANNALS OF THORACIC SURGERY, 2016
79
The use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and its Differential Diagnosis
정진행, Thunnissen E
JOURNAL OF THORACIC ONCOLOGY, 2016
80
EGFR protein expression using a specific intracellular domain antibody and PTEN and clinical outcomes in squamous cell lung cancer patients with EGFR-tyrosine kinase inhibitor therapy